William J. Golden
Oprichter bij Lancet Capital Partners LLC
Actieve functies van William J. Golden
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Lancet Capital Partners LLC
Lancet Capital Partners LLC Investment ManagersFinance Lancet Capital Partners LLC (Lancet Capital Partners) is a venture capital firm founded in 1998 by William J. Golden and George L. Sing. The firm is headquartered in Pittsburgh, Pennsylvania. | Oprichter | 01-07-1997 | - |
Private Equity Investor | 01-07-1997 | - |
Loopbaan van William J. Golden
Eerdere bekende functies van William J. Golden
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Noveome Biotherapeutics, Inc.
Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Noveome Biotherapeutics, Inc. develops novel biotherapeutic products that restore cell communication and system homeostasis. Its proprietary technology platform, derived from human placental cells, provides an exciting new approach to tissue regeneration and repair in a wide range of medical conditions and offers hope, especially in patients with maladies. The company was founded in 2001 by George L. Sing and William J. Golden and is headquartered in Pittsburgh, PA. | Algemeen Directeur | 01-06-2021 | 01-01-2022 |
Voorzitter | 01-06-2021 | 01-01-2022 | |
Financieel Directeur/CFO | 01-06-2021 | 01-01-2022 | |
Oprichter | 01-06-2021 | 01-01-2022 | |
Boston University Office of Technology Development
Boston University Office of Technology Development Investment ManagersFinance The Boston University Office of Technology Development invests through the Boston University Technology Fund. The Fund provides venture capital and access to Boston University's scientific and technical resources for promising companies | Corporate Officer/Principal | - | 31-12-1997 |
Boston University Technology Development Fund
Boston University Technology Development Fund Investment ManagersFinance Boston University Community Technology Fund invests in companies located in the US. The fund targets companies operating in the fields of technology and life science companies. It provides financing for seed and early stage capital requirements with an investment size in the range of $0.5 - $1 million. It invests in venture capital funds and also makes co-investments. | Consultant / Adviseur | 01-09-1992 | 01-07-1997 |
Private Equity Investor | 01-09-1992 | 01-07-1997 | |
VivoQuest, Inc.
VivoQuest, Inc. BiotechnologyHealth Technology VivoQuest, Inc. is engaged into the discovery and development of prescription drugs based on natural compounds derived small molecules. The in-house discovery research program in chemistry and biology aims at establishing and screening unique libraries of natural product-like compounds. VivoQuest's initial therapeutic area is the anti-viral field, including HIV and hepatitis C. VivoQuest is headquartered in Valley Cottage, NY. | Financieel Directeur/CFO | - | - |
Arthur D. Little, Inc.
Arthur D. Little, Inc. Miscellaneous Commercial ServicesCommercial Services Arthur D. Little, Inc. engages in the provision of management consulting services. It specializes in strategy and organization, operations management, technology and innovation management, corporate finance, and global carbon advisory serving corporations and organizations worldwide. The firm serves the automotive, healthcare, information, chemicals, consumer goods, retail, manufacturing, and transportation industries. The company was founded by Arthur Dehon Little and Roger Griffin in October 1886 and is headquartered in Boston, MA. | Corporate Officer/Principal | - | - |
Opleiding van William J. Golden
Harvard University | Masters Business Admin |
University of Notre Dame | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 8 |
2 |
Operationeel
Founder | 2 |
Private Equity Investor | 2 |
Corporate Officer/Principal | 2 |
Sectoraal
Finance | 4 |
Health Technology | 3 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 6 |
---|---|
Lancet Capital Partners LLC
Lancet Capital Partners LLC Investment ManagersFinance Lancet Capital Partners LLC (Lancet Capital Partners) is a venture capital firm founded in 1998 by William J. Golden and George L. Sing. The firm is headquartered in Pittsburgh, Pennsylvania. | Finance |
Arthur D. Little, Inc.
Arthur D. Little, Inc. Miscellaneous Commercial ServicesCommercial Services Arthur D. Little, Inc. engages in the provision of management consulting services. It specializes in strategy and organization, operations management, technology and innovation management, corporate finance, and global carbon advisory serving corporations and organizations worldwide. The firm serves the automotive, healthcare, information, chemicals, consumer goods, retail, manufacturing, and transportation industries. The company was founded by Arthur Dehon Little and Roger Griffin in October 1886 and is headquartered in Boston, MA. | Commercial Services |
VivoQuest, Inc.
VivoQuest, Inc. BiotechnologyHealth Technology VivoQuest, Inc. is engaged into the discovery and development of prescription drugs based on natural compounds derived small molecules. The in-house discovery research program in chemistry and biology aims at establishing and screening unique libraries of natural product-like compounds. VivoQuest's initial therapeutic area is the anti-viral field, including HIV and hepatitis C. VivoQuest is headquartered in Valley Cottage, NY. | Health Technology |
Boston University Office of Technology Development
Boston University Office of Technology Development Investment ManagersFinance The Boston University Office of Technology Development invests through the Boston University Technology Fund. The Fund provides venture capital and access to Boston University's scientific and technical resources for promising companies | Finance |
Noveome Biotherapeutics, Inc.
Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Noveome Biotherapeutics, Inc. develops novel biotherapeutic products that restore cell communication and system homeostasis. Its proprietary technology platform, derived from human placental cells, provides an exciting new approach to tissue regeneration and repair in a wide range of medical conditions and offers hope, especially in patients with maladies. The company was founded in 2001 by George L. Sing and William J. Golden and is headquartered in Pittsburgh, PA. | Health Technology |
Boston University Technology Development Fund
Boston University Technology Development Fund Investment ManagersFinance Boston University Community Technology Fund invests in companies located in the US. The fund targets companies operating in the fields of technology and life science companies. It provides financing for seed and early stage capital requirements with an investment size in the range of $0.5 - $1 million. It invests in venture capital funds and also makes co-investments. | Finance |
- Beurs
- Insiders
- William J. Golden
- Ervaring